Announcements Trials
Browse Landscape

Phase

Phase 2 159Phase 1 85Phase 3 48Phase 1/2 42Phase NA 29Phase EARLY_PHASE1 6Phase 4 4Phase 2/3 3

Status

Recruiting 5Completed 3Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Plasma cell 3

Conditions

Breast Neoplasms 40Neoplasms 36Prostatic Neoplasms 32Colorectal Neoplasms 22Carcinoma, Non-Small-Cell Lung 22Leukemia, Myeloid, Acute 21Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Neoplasm Metastasis 14Polycystic Ovary Syndrome 13Lung Neoplasms 13Stomach Neoplasms 12Multiple Myeloma 11Carcinoma, Hepatocellular 11Recurrence 10Pancreatic Neoplasms 10Urinary Bladder Neoplasms 9Lymphoma 9Leukemia 9Myelodysplastic Syndromes 8Motor Activity 8Head and Neck Neoplasms 8Liver Neoplasms 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7Esophageal Neoplasms 7Colonic Neoplasms 7Brain Neoplasms 7Pain 6Ovarian Neoplasms 6Lymphoma, Non-Hodgkin 6Lymphoma, Follicular 6

Interventions

Dexamethasone 2daratumumab 1Thalidomide 1MAGEA3 protein, human 1Lenalidomide 1Calcium Dobesilate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × Completed × Neoplasms, Plasma Cell × Clear all
NCT00038090 2018-10-31

Thalidomide-Dexamethasone for Multiple Myeloma

M.D. Anderson Cancer Center

Phase 2/3 Completed
83 enrolled
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

NCT02419118 2017-11-07

DARA

Vejle Hospital

Phase 2/3 Completed
4 enrolled
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00090493 2013-06-24

Study of MAGE-A3 and NY-ESO-1 Immunotherapy in Combo With DTPACE Chemo and Auto Transplantation in Multiple Myeloma

University of Arkansas

Phase 2/3 Completed
4 enrolled 6 charts
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡